ABION is the Korean drug discovery company with the pioneering spirit.
Established in 2007, Abion was the first Korean biopharma to advance the concept of precision oncology.
The company has robust pipeline for drug candidates in preclinical stage, clinical phase 1 and phase 2 to treat lung cancers and infectious diseases and is actively seeking research and clinical partnerships.
Abion Youtube channel
☞ https://www.youtube.com/@abionbio
Company Details
- Employees
- 27
- Founded
- -
- Address
- 242 Digital-Ro, Guro-Gu, Seoul,korea, Republic Of
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- abionbio.com
- HQ
- Seoul
Abion Inc. Questions
Abion Inc.'s website is abionbio.com
Abion Inc.'s LinkedIn profile is https://kr.linkedin.com/company/abionbio
Abion Inc. has
27 employees.
View email and phone details for 27
employees at Abion Inc..
Abion Inc.'s industry is
Biotechnology Research
Abion Inc.'s top competitors are
Boryung,
Abion,
Hk Inno-N,
Idience,
Lunit Cancer Screening,
Hanmi Pharmaceutical (한미약품),
Onconic Therapeutics,
Aptabio,
Immuneoncia Therapeutics Inc.,
Daehwa Pharmaceutical Co., Ltd..
Abion Inc.'s categories are Biotechnology Research
Abion Inc.'s founding year is 2007
